Wire Stories
Genetron Health Releases New Data Results of HCCscreen� for Liver Cancer Early Screening in China
HCCscreenTM achieved 88% sensitivity and 93% specificity, compared with 71% and 95%, respectively, by ultrasound plus AFP. In early-stage patients, the sensitivities...